Atheroprotective effects of 17ß-oestradiol are mediated by peroxisome proliferator-activated receptor Î³ in human coronary artery smooth muscle cells.

Jehle, Julian; Tiyerili, Vedat; Adler, Sandra; Groll, Katharina; Nickenig, Georg; Becher, Ulrich M

Jehle, Julian; Tiyerili, Vedat; Adler, Sandra; Groll, Katharina; Nickenig, Georg; Becher, Ulrich M.

Afiliación

Jehle J; Department of Internal Medicine II, Cardiology, Pneumology, and Angiology, University Hospital Bonn, Bonn, Germany.
Tiyerili V; Department of Internal Medicine II, Cardiology, Pneumology, and Angiology, University Hospital Bonn, Bonn, Germany.
Adler S; Department of Internal Medicine II, Cardiology, Pneumology, and Angiology, University Hospital Bonn, Bonn, Germany.
Groll K; Department of Internal Medicine II, Cardiology, Pneumology, and Angiology, University Hospital Bonn, Bonn, Germany.
Nickenig G; Department of Internal Medicine II, Cardiology, Pneumology, and Angiology, University Hospital Bonn, Bonn, Germany.
Becher UM; Department of Internal Medicine II, Cardiology, Pneumology, and Angiology, University Hospital Bonn, Bonn, Germany.

Arch Med Sci Atheroscler Dis ; 5: e118-e126, 2020.

Article en En | MEDLINE | ID: mdl-32665986

Palabras clave

17ß-oestradiol; human coronary artery smooth muscle cells; oestrogen receptor α; peroxisome-proliferator-activated-receptor-Î³; propylpyrazole triol

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Arch Med Sci Atheroscler Dis Año: 2020 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Polonia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google